Roche’s Genentech Bid Turns Hostile
Saturday, January 31, 2009 - 02:43
in Mathematics & Economics
Roche said it would pay a lower price than it had offered last July for the 44 percent of Genentech it does not already own and that it would go directly to shareholders with its offer.
Read the whole article on NY Times Health
More from NY Times Health
Related
- UC San Diego and Genentech scientists develop potentially disruptive antibody sequencing technologyFri, 19 Dec 2008, 11:29:51 EST
- Genentech uses Complete Genomics' human genome sequencing service to compare tumor and normal genome in patient with non-small cell lung cancer; results published in NatureWed, 26 May 2010, 18:07:17 EDT
- Foreclosure reduces a home's sale price by 27 percent on averageWed, 4 Aug 2010, 15:32:59 EDT
- Bypassing stem cells, scientists make neurons directly from human skinThu, 4 Aug 2011, 14:37:15 EDT
- Promising early evidence of the superior benefits of drug therapy for diabetic eye diseaseWed, 30 Apr 2008, 14:58:02 EDT